Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fulcrum Therapeutics (FULC) Return on Assets (2019 - 2025)

Fulcrum Therapeutics (FULC) has disclosed Return on Assets for 7 consecutive years, with 0.26% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 10.0% to 0.26% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.26%, a 10.0% decrease, with the full-year FY2025 number at 0.24%, down 20.0% from a year prior.
  • Return on Assets was 0.26% for Q4 2025 at Fulcrum Therapeutics, up from 0.32% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q2 2023 to a low of 0.5% in Q2 2022.
  • A 5-year average of 0.27% and a median of 0.24% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: soared 41bps in 2023, then fell -23bps in 2025.
  • Fulcrum Therapeutics' Return on Assets stood at 0.33% in 2021, then rose by 23bps to 0.25% in 2022, then rose by 23bps to 0.19% in 2023, then grew by 17bps to 0.16% in 2024, then plummeted by -60bps to 0.26% in 2025.
  • Per Business Quant, the three most recent readings for FULC's Return on Assets are 0.26% (Q4 2025), 0.32% (Q3 2025), and 0.22% (Q2 2025).